One year in review 2020: novelties in the treatment of rheumatoid arthritis

M D'Amico, C Scire, T Huizinga - Clinical and experimental …, 2020 - boa.unimib.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
被引用次数：61 相关文章
[PDF] clinexprheumatol.org

[PDF][PDF] One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clin Exp …, 2020 - clinexprheumatol.org
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
[PDF] unimib.it

[PDF][PDF] One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clin Exp …, 2020 - boa.unimib.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2020: novelties in the treatment of rheumatoid arthritis.

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clinical and …, 2020 - europepmc.org
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - CLINICAL AND …, 2020 - sfera.unife.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou… - Clinical and …, 2020 - pubmed.ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo… - Clinical and …, 2020 - scholarlypublications …
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
[PDF] unife.it

[PDF][PDF] One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clin Exp …, 2020 - iris.unife.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - CLINICAL AND …, 2020 - iris.unipv.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …
[PDF] unife.it

[PDF][PDF] One year in review 2020: novelties in the treatment of rheumatoid arthritis

E Silvagni, A Giollo, G Sakellariou, N Ughi… - Clin Exp …, 2020 - sfera.unife.it
Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …